Article
Evaluation of a commercial microarray as a confirmation test for the presence of extended-spectrum β-lactamases in isolates from the routine clinical setting.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases - 1 Sept 2011
Platteel T N, Stuart J W Cohen, Voets G M, Scharringa J, van de Sande N, Fluit A C, Leverstein-Van Hall M A
Abstract excerpt
Since the diagnostic characteristics of the Check-KPC ESBL microarray as a confirmation test on isolates obtained in a routine clinical setting have not been determined, we evaluated the microarray in a random selection of 346 clinical isolates with a positive ESBL screen test (MIC >1 mg/L for cefotaxime or ceftazidime or an ESBL alarm from the Phoenix or Vitek-2 expert system) collected from 31 clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.